Related Experiment Video
Updated: Dec 10, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Staphylococcus Aureus Panton-Valentine Leukocidin causing hip osteomyelitis, thrombophlebitis and necrotizing
M S Cori1, G Ronconi2, E Masiello1
1Pediatric Institute Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome Italy.
Insights
Panton-Valentine leukocidin (PVL) is a dangerous toxin from Staphylococcus aureus. This case highlights severe PVL-associated osteomyelitis in a child, stressing the need for early recognition and management.
Area of Science:
- Microbiology
- Toxicology
- Infectious Diseases
Background:
- Panton-Valentine leukocidin (PVL) is a key virulence factor in Staphylococcus aureus, responsible for leukocyte destruction and tissue necrosis.
- PVL-producing Staphylococcus aureus (PVL-SA) infections, particularly osteomyelitis, pose significant clinical challenges.
- Data on PVL-SA prevalence in Italy are limited, potentially leading to under-recognition.
Observation:
- A pediatric case of hip joint osteomyelitis with associated thrombophlebitis, necrotizing pneumonia, and septic shock is presented.
- The patient required extensive intensive care unit (ICU) support, including mechanical ventilation and circulatory support.
- Management involved surgical drainage and prolonged second-line antibiotic therapy.
Findings:
- The case underscores the severe complications associated with PVL-SA osteomyelitis in children.
- Over half of PVL-SA strains in Europe are Methicillin-Susceptible Staphylococcus Aureus (MSSA), complicating initial treatment decisions.
- Diagnostic challenges exist due to the variable availability of PVL testing.
Implications:
- Early recognition of clinical features suggestive of PVL-SA osteomyelitis in pediatric patients is crucial.
- Prompt and adequate management, including appropriate antibiotic selection and surgical intervention, is vital for patient outcomes.
- Further epidemiological studies on PVL-SA prevalence in Italy are needed to guide clinical practice and public health strategies.
Abstract:
Panton-Valentine leukocidin (PVL) represents an important virulence factor for many strains of Staphylococcus aureus. PVL is an esotoxin causing leucocyte destruction and tissue necrosis. We report on a case of osteomyelitis involving the hip joint with thromblophlebitis complicated by necrotizing pneumonia and life-threatening septic shock. The child required advance respiratory support for 14 days with circulatory support for 7 days in ICU (intensive care unit), surgical draninage via arthrotomy of hip joint and second-line antibiotic treatment for 1 month. Among a wide literature, in Europe over half of Panton-Valentine St. Aureus (PVL-SA) is MSSA. Investigations for PVL are not always available determining an under-recognition of the episodes. Data on prevalence of PVL-SA in Italy are scarce. With this clinical report, we emphasize the recognition of clinical features that must lead to suspect PVL-SA osteomyelitis in children, providing their adequate management.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Endocarditis I: Introduction